Validea Joel Greenblatt Daily Strategy Update Report – 11/06/2021

0

THere are today’s updates for Validea Profit Yield Investor model based on the published strategy of Joel greenblatt. This value model seeks companies with high return on capital and high profits.

TOWNSQUARE MEDIA INC (TSQ) is a small cap value stock in the advertising industry. The rating according to our strategy based on Joel Greenblatt has increased from 80% to 90% depending on the underlying fundamentals of the company and the valuation of the stock. A score of 80% or more usually indicates that the strategy has some interest in the stock and a score above 90% generally indicates a strong interest.

Business Description: Townsquare Media, Inc. is a community-driven digital media, digital marketing and radio solutions company. It operates through three segments: Advertising, Townsquare Interactive and Live Events. The Advertising segment comprises the broadcast operations of the Company’s radio stations, as well as its owned and operated websites and the various digital advertising solutions it offers, including Townsquare Ignite, the Company’s digital programmatic advertising platform. . Townsquare Interactive provides digital, subscription-based marketing solutions to local and regional small and medium-sized businesses in small to medium-sized markets across the United States. The Live Events segment includes ticket sales, sponsorship sales, food and other concessions, merchandise, and other ancillary products and services. The Company owns and operates approximately 322 radio stations and over 330 local websites in 67 markets across the United States.

The following table summarizes whether the title meets each of the tests for this strategy. Not all of the criteria in the table below are given the same weight or are independent, but the table gives a brief overview of the strengths and weaknesses of the title in the context of the strategy criteria.

BENEFICIARY RETURN: NEUTRAL
RETURN ON BODILY CAPITAL: NEUTRAL
FINAL CLASSIFICATION: PAST

Detailed analysis of TOWNSQUARE MEDIA INC

Full Guru Analysis for TSQ

Full Factor Report for TSQ

ENDO INTERNATIONAL PLC (ENDP) is a small-cap growth stock in the biotechnology and drugs sector. The rating according to our strategy based on Joel Greenblatt has increased from 0% to 80% depending on the underlying fundamentals of the company and the valuation of the stock. A score of 80% or more usually indicates that the strategy has some interest in the stock and a score above 90% generally indicates a strong interest.

Company Description: Endo International plc is a generic and specialty brand pharmaceutical company. The Company operates through three segments: US Generic Pharmaceuticals, US Branded Pharmaceuticals and International Pharmaceuticals. It has a branded pharmaceutical portfolio offered by its branded pharmaceuticals segment in the United States which includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its US portfolio of unbranded generic pharmaceuticals includes products such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company’s generic portfolio includes a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and global markets.

The following table summarizes whether the title meets each of the tests for this strategy. Not all of the criteria in the table below are given the same weight or are independent, but the table gives a brief overview of the strengths and weaknesses of the title in the context of the strategy criteria.

BENEFICIARY RETURN: NEUTRAL
RETURN ON BODILY CAPITAL: NEUTRAL
FINAL CLASSIFICATION: TO FAIL

Detailed analysis of ENDO INTERNATIONAL PLC

Full Guru Analysis for ENDP

Full Factor Report for ENDP

NOMAD FOODS LTD (NOMD) is a mid-cap growth stock in the food processing industry. The rating according to our strategy based on Joel Greenblatt has increased from 70% to 80% depending on the underlying fundamentals of the company and the valuation of the stock. A score of 80% or more usually indicates that the strategy has some interest in the stock and a score above 90% generally indicates a strong interest.

Company Description: Nomad Foods Limited is a frozen food company. The Company is engaged in building a global portfolio of food companies and brands in the frozen food category and across the food industry. The Company is a branded frozen food player in Western Europe with a portfolio of food brands in the frozen food category including fish, vegetables, poultry, meals and pizza. Its products are mainly sold through food retailers under the Birds Eye, Aunt Bessie’s and Goodfella’s brands in the UK and Ireland, Findus in Italy, France, Spain, Sweden, Switzerland and Norway, Igno in Germany and other continental markets and La Cocinera in Spain. The company produces, markets and distributes brands through offices in over 14 countries and exports to many more. Its product offerings include frozen fish products such as fish fingers, coated fish, natural fish; ready-to-cook plant products like peas and spinach; and frozen poultry and meat products such as nuggets, grilled meats and burgers.

The following table summarizes whether the title meets each of the tests for this strategy. Not all of the criteria in the table below are given the same weight or are independent, but the table gives a brief overview of the strengths and weaknesses of the title in the context of the strategy criteria.

BENEFICIARY RETURN: NEUTRAL
RETURN ON BODILY CAPITAL: NEUTRAL
FINAL CLASSIFICATION: TO FAIL

Detailed analysis of NOMAD FOODS LTD

Full Guru Analysis for NOMD

Full Factor Report for NOMD

MODERNA INC (MRNA) is a large cap value equity in the biotechnology and drugs sector. The rating according to our strategy based on Joel Greenblatt has increased from 70% to 80% depending on the underlying fundamentals of the company and the valuation of the stock. A score of 80% or more usually indicates that the strategy has some interest in the stock and a score above 90% generally indicates a strong interest.

Company Description: Moderna, Inc. is a biotechnology company focused on creating transformative drugs, based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA-based drugs are designed to direct body cells to the production of intracellular, membrane or secreted proteins that have therapeutic or preventative benefit with the potential to treat a wide range of diseases. It develops vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA-based drugs for various applications. He has created modalities including prophylactic vaccines, systemic secreted and cell surface therapies, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapies, and systemic intracellular therapies.

The following table summarizes whether the title meets each of the tests for this strategy. Not all of the criteria in the table below are given the same weight or are independent, but the table gives a brief overview of the strengths and weaknesses of the title in the context of the strategy criteria.

BENEFICIARY RETURN: NEUTRAL
RETURN ON BODILY CAPITAL: NEUTRAL
FINAL CLASSIFICATION: TO FAIL

Detailed analysis of MODERNA INC

Complete guru analysis for mRNA

Full Factor Report for mRNA

WHITING PETROLEUM CORP (WLL) is a mid-cap growth stock in the oil and gas operations sector. The rating according to our strategy based on Joel Greenblatt has increased from 70% to 100% depending on the underlying fundamentals of the company and the valuation of the stock. A score of 80% or more usually indicates that the strategy has some interest in the stock and a score above 90% generally indicates a strong interest.

Company Description: Whiting Petroleum Corporation is an independent oil and gas company with an oil-focused asset base. The Company is a producer of crude oil in North Dakota and operates significant assets in northern Colorado. The Company is involved in development, production, acquisition and exploration activities primarily in the Rocky Mountain region of the United States. It is engaged in the exploration and production of crude oil, liquid natural gas (NGL) and natural gas. The Company’s other activities relate primarily to non-core assets in Arkansas, Mississippi, New Mexico, Texas and Wyoming. The Company holds interests in producing wells on developed acres in its geographic areas. It sells its oil and gas production to end users, traders and other buyers who have access to a nearby pipeline or railroad.

The following table summarizes whether the title meets each of the tests for this strategy. Not all of the criteria in the table below are given the same weight or are independent, but the table gives a brief overview of the strengths and weaknesses of the title in the context of the strategy criteria.

BENEFICIARY RETURN: NEUTRAL
RETURN ON BODILY CAPITAL: NEUTRAL
FINAL CLASSIFICATION: PAST

Detailed analysis of WHITING PETROLEUM CORP

Full Guru Analysis for WLL

Full factor ratio for WLL

More details on Validea’s Joel Greenblatt strategy

Joel Greenblatt Ideas for action

About Joel Greenblatt: In his 2005 bestseller, The Little Book That Beats the Market, hedge fund manager Joel Greenblatt presented a surprisingly simple way to beat the market using two – and only two – fundamental variables. The “magic formula,” as he called it, produced post-tested returns of 30.8% per annum from 1988 to 2004, more than doubling the 12.4% return of the S&P 500 during that time. Greenblatt also produced exceptional returns as a managing partner of Gotham Capital, a New York-based hedge fund he founded. The company has averaged a remarkable 40% annualized return over more than two decades.

About Validea: Validea is an investment research service that tracks strategies published by investment legends. Validea offers both equity analysis and model portfolios based on gurus who have outperformed the market over the long term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information on Validea, Click here

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Source link

Share.

About Author

Leave A Reply